Multiple Assemblies exist for SMTL entry 5ewa
Crystal structure of the metallo-beta-lactamase IMP-1 in complex with the bisthiazolidine inhibitor L-VC26; X-RAY DIFFRACTION 2.30 Å

	SMTL ID 5ewa.1 Ligands ZINC ION; (3~{R},5~{R},7~{a}~{S})-2,2-dimethyl-5-(sulfanylmethyl)-3,5,7,7~{a}-tetrahydro-[1,3]thiazolo[4,3-b][1,3]thiazole-3-carboxylic acid; 1,2-ETHANEDIOL Polypeptides Beta-lactamase IMP-1 Oligo-state monomer
	SMTL ID 5ewa.2 Ligands ZINC ION; (3~{R},5~{R},7~{a}~{S})-2,2-dimethyl-5-(sulfanylmethyl)-3,5,7,7~{a}-tetrahydro-[1,3]thiazolo[4,3-b][1,3]thiazole-3-carboxylic acid Polypeptides Beta-lactamase IMP-1 Oligo-state monomer
	SMTL ID 5ewa.3 Ligands ZINC ION; DIMETHYL SULFOXIDE; (3~{R},5~{R},7~{a}~{S})-2,2-dimethyl-5-(sulfanylmethyl)-3,5,7,7~{a}-tetrahydro-[1,3]thiazolo[4,3-b][1,3]thiazole-3-carboxylic acid Polypeptides Beta-lactamase IMP-1 Oligo-state monomer
	SMTL ID 5ewa.4 Ligands ZINC ION; (3~{R},5~{R},7~{a}~{S})-2,2-dimethyl-5-(sulfanylmethyl)-3,5,7,7~{a}-tetrahydro-[1,3]thiazolo[4,3-b][1,3]thiazole-3-carboxylic acid Polypeptides Beta-lactamase IMP-1 Oligo-state monomer